These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28925507)

  • 21. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
    Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
    BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.
    Song X; Gao T; Wang N; Feng Q; You X; Ye T; Lei Q; Zhu Y; Xiong M; Xia Y; Yang F; Shi Y; Wei Y; Zhang L; Yu L
    Sci Rep; 2016 Feb; 6():20864. PubMed ID: 26868841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.
    Maruyama T; Murata S; Nakayama K; Sano N; Ogawa K; Nowatari T; Tamura T; Nozaki R; Fukunaga K; Ohkohchi N
    Oncol Rep; 2014 Feb; 31(2):625-33. PubMed ID: 24337301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
    Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose.
    Wang Q; Xu L; Zhang X; Liu D; Wang R
    Eur J Pharmacol; 2020 Aug; 880():173076. PubMed ID: 32222493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
    Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
    J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
    Bownes LV; Williams AP; Marayati R; Stafman LL; Markert H; Quinn CH; Wadhwani N; Aye JM; Stewart JE; Yoon KJ; Mroczek-Musulman E; Beierle EA
    PLoS One; 2021; 16(3):e0246244. PubMed ID: 33690617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells.
    Liu TP; Lo HL; Wei LS; Hsiao HH; Yang PM
    Anticancer Drugs; 2015 Feb; 26(2):139-47. PubMed ID: 25203626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells.
    Sharma C; Nusri Qel-A; Begum S; Javed E; Rizvi TA; Hussain A
    Asian Pac J Cancer Prev; 2012; 13(9):4815-22. PubMed ID: 23167425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
    Bugide S; Gupta R; Green MR; Wajapeyee N
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.
    Oki S; Sone K; Oda K; Hamamoto R; Ikemura M; Maeda D; Takeuchi M; Tanikawa M; Mori-Uchino M; Nagasaka K; Miyasaka A; Kashiyama T; Ikeda Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Kawana K; Fukayama M; Osuga Y; Fujii T
    Oncotarget; 2017 Jun; 8(25):40402-40411. PubMed ID: 28418882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
    Bai J; Ma M; Cai M; Xu F; Chen J; Wang G; Shuai X; Tao K
    Cell Prolif; 2014 Jun; 47(3):211-8. PubMed ID: 24738879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
    Hwang YS; Park KK; Chung WY
    Eur J Pharmacol; 2013 Sep; 715(1-3):286-95. PubMed ID: 23707351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
    Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.
    Yu T; Wang Y; Hu Q; Wu W; Wu Y; Wei W; Han D; You Y; Lin N; Liu N
    Oncotarget; 2017 Nov; 8(58):98348-98359. PubMed ID: 29228694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway.
    Ma YC; Li C; Gao F; Xu Y; Jiang ZB; Liu JX; Jin LY
    Oncol Rep; 2014 Mar; 31(3):1343-9. PubMed ID: 24366444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
    Park SB; Bae JW; Kim JM; Lee SG; Han M
    Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells.
    Du GJ; Wang CZ; Qi LW; Zhang ZY; Calway T; He TC; Du W; Yuan CS
    Phytother Res; 2013 Feb; 27(2):272-7. PubMed ID: 22566066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.